Xeltis
8 known investors
Xeltis is a medtech company developing bioresorbable vascular implants, such as its aXess conduit for hemodialysis access, that are gradually replaced by the patient's own living tissue. Its Restorex supramolecular polymer technology targets vascular applications including dialysis access, arterial bypass surgery, and pulmonary heart valves for patients undergoing vascular surgery.
BiotechHealthtechMedical Devices
Founders & leadership
ES
Eliane SchutteCEO
Investors · 8
Kurma PartnersParis · $162K – $10.8M
VI PartnersAltendorf · $2.2M – $4.5M
Ysios CapitalBarcelona · $5.4M – $21.6M
EQT Life Sciencesreported · 2 sourcesLuxembourg · $11M – $66M
Invest-NLreported · 2 sourcesAmsterdam
Also in the syndicate · 3
DaVitaEuropean Innovation CouncilHorizon 3 Healthcarelead
In the news
Frequently asked questions
- What does Xeltis do?
- Xeltis is a medtech company developing bioresorbable vascular implants, such as its aXess conduit for hemodialysis access, that are gradually replaced by the patient's own living tissue. Its Restorex supramolecular polymer technology targets vascular applications including dialysis access, arterial bypass surgery, and pulmonary heart valves for patients undergoing vascular surgery.
- Who are Xeltis's investors?
- Xeltis's investors include Kurma Partners, VI Partners, Ysios Capital, EQT Life Sciences, Invest-NL.